Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Alla Mitrofanova, Shamroop Kumar Mallela, Gloria Michelle Ducasa, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Emerging Targets in Type 2 Diabetes and Diabetic Complications
Sevgican Demir, Peter P. Nawroth, Stephan Herzig, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 322
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 250
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Lucas Opazo-Ríos, Sebastián Mas, Gema Marín‐Royo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2632-2632
Open Access | Times Cited: 248
A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
Brianna M. Quinville, Natalie M. Deschenes, Alex E. Ryckman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5793-5793
Open Access | Times Cited: 195
Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy
Ming Wu, Zhifen Yang, Chengyu Zhang, et al.
Metabolism (2021) Vol. 118, pp. 154748-154748
Closed Access | Times Cited: 124
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 629-645
Closed Access | Times Cited: 111
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
Yi Fu, Yu Sun, Mei Wang, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1052-1062.e8
Open Access | Times Cited: 136
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
Judy Baek, Chenchen He, Farsad Afshinnia, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 1, pp. 38-55
Open Access | Times Cited: 99
Role of ceramides in the pathogenesis of diabetes mellitus and its complications
Nawajes Mandal, Richard C. Grambergs, Koushik Mondal, et al.
Journal of Diabetes and its Complications (2020) Vol. 35, Iss. 2, pp. 107734-107734
Open Access | Times Cited: 74
New insights into renal lipid dysmetabolism in diabetic kidney disease
Alla Mitrofanova, George W. Burke, Sandra Merscher, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 5, pp. 524-540
Open Access | Times Cited: 58
Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases
Alla Mitrofanova, Antonio M. Fontanella, Matthew Tolerico, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 12, pp. 2153-2173
Open Access | Times Cited: 47
Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease
Gloria Michelle Ducasa, Alla Mitrofanova, Alessia Fornoni
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Closed Access | Times Cited: 67
The Contribution of Lipotoxicity to Diabetic Kidney Disease
Jeffrey R. Schelling
Cells (2022) Vol. 11, Iss. 20, pp. 3236-3236
Open Access | Times Cited: 35
Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
Rachel Njeim, Sahar Alkhansa, Alessia Fornoni
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1360-1360
Open Access | Times Cited: 18
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Draženka Pongrac Barlovič, Valma Harjutsalo, Niina Sandholm, et al.
Diabetologia (2020) Vol. 63, Iss. 9, pp. 1847-1856
Open Access | Times Cited: 44
Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
Yelena Drexler, Judith Molina, Alla Mitrofanova, et al.
Journal of the American Society of Nephrology (2020) Vol. 32, Iss. 1, pp. 9-31
Open Access | Times Cited: 40
The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease
Yu Sun, Sijia Cui, Yunfeng Hou, et al.
Kidney Diseases (2021) Vol. 7, Iss. 6, pp. 438-451
Open Access | Times Cited: 38
The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides
Xiaohong Zhang, Xue-Zhen Zhu, Xiaoyang Bi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7793-7793
Open Access | Times Cited: 27
Implications of Sphingolipid Metabolites in Kidney Diseases
Shamroop Kumar Mallela, Sandra Merscher, Alessia Fornoni
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4244-4244
Open Access | Times Cited: 25
Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 5, pp. 862-878
Closed Access | Times Cited: 39
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
Taesik Gwag, Raja Gopal Reddy Mooli, Dong Li, et al.
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100193-100193
Open Access | Times Cited: 37
SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B
Wei Fan, Shuang Tang, Xiaojuan Fan, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 30
Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
Shilu Luo, Ming Yang, Hao Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
Matthew Tolerico, Sandra Merscher, Alessia Fornoni
Cells (2024) Vol. 13, Iss. 11, pp. 890-890
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top